Heparin "leo" (Heparin Sodium)

Heparin "leo" is employed in several clinical settings where inhibition of clot formation is required.

• Prevention and treatment of venous thromboembolism, including deep‑vein thrombosis and pulmonary embolism.
• Management of acute coronary syndromes such as unstable angina and myocardial infarction.
• Anticoagulation during cardiac surgery, including coronary artery bypass grafting.
• Prevention of clotting in patients undergoing hemodialysis or extracorporeal circulation.
• Use in interventional radiology procedures to maintain catheter patency.

Heparin "leo" may cause a range of side effects, most of which are related to its anticoagulant activity.

Common

• Minor bleeding from gums, nose, or minor cuts.
• Injection site bruising or erythema.
• Elevated liver enzymes detected on laboratory testing.
• Transient thrombocytopenia (low platelet count).

Serious

• Major hemorrhage, including intracranial or gastrointestinal bleeding.
• Heparin‑induced thrombocytopenia (HIT) with paradoxical clot formation.
• Severe allergic reactions such as anaphylaxis.
• Spontaneous spinal or epidural hematoma.

When prescribing or receiving Heparin "leo", several safety considerations should be observed.

• Assess baseline coagulation parameters and platelet count before initiation.
• Adjust dosage in patients with renal or hepatic impairment.
• Monitor for signs of bleeding, especially in surgical or trauma patients.
• Use caution in pregnant or breastfeeding women; risk‑benefit assessment is required.
• Avoid concurrent use with other anticoagulants or antiplatelet agents unless specifically indicated.
• Educate patients on recognizing symptoms of serious bleeding or allergic reactions.

Heparin "leo" can interact with various medications, influencing its anticoagulant effect.

Avoid

• Concurrent use with other anticoagulants (e.g., warfarin, direct oral anticoagulants) without close monitoring.
• Combination with antiplatelet drugs such as aspirin, clopidogrel, or NSAIDs, which may increase bleeding risk.
• Use with fibrinolytic agents (e.g., alteplase) due to additive hemorrhagic potential.

Use with caution

• Concurrent administration of certain antibiotics (e.g., vancomycin) that may potentiate thrombocytopenia.
• Over-the-counter supplements like ginkgo biloba, garlic, or high‑dose vitamin E, which can affect clotting.
• Hormonal therapies (e.g., estrogen‑containing contraceptives) that may modify coagulation balance.